Diversification via an ETF can help biotech investors avoid boom-or-bust volatility while still capitalizing on long-term growth trends.

Biotech ETFs face a pivotal week as Summit Therapeutics SMMT approaches a key FDA decision, while fresh drug-development ...

Designed to provide broad exposure to the Health Care ETFs category of the market, the iShares Biotechnology ETF (IBB) is a smart beta exchange traded fund launched on 02/05/2001. What Are Smart Beta ...

RSPH offers broader sector diversification with lower volatility, while XBI delivers higher short-term gains but with steeper ...

IHE offers lower costs and higher income through a concentrated play on established drugmakers, while IBB provides broader ...

Both ETFs offer investors a way to profit from advances in medicine, but a closer look reveals a clear winner.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Scientists meticulously analyze complex data on a monitor ...

Moderna gave investors a scare as its stock plunged on Thursday. But it's still one of the hottest biotechs this year. And it's hardly alone – the sector is on a roll and looks poised for more gains.

The biotechnology sector continued its advance on Tuesday, with the iShares Biotechnology ETF (IBB) reaching a record intraday high of $179.95 as investor interest in the industry remained strong. The ...

SA Spotlight uses AI to summarize content published on Seeking Alpha. All summaries are reviewed by human editors prior to publication. A positive Phase 3 readout in melanoma has acted as a ...

Healthcare has been one of the better performing corners of the U.S. market in 2026, but how much an investor made depends heavily on which slice of the sector they owned. According to ETF.com ...

The strategic use of certain ETFs can help investors turn unrealized stock-picking losses into tangible tax savings.